Nemesis Bioscience Closes Funding Round And Begins Preclinical Programmes
Nemesis Bioscience today announced the successful completion of its latest funding round, bringing total...
read moreThe Rainbow Seed Fund’s impact is not simply in economic terms such as jobs and Gross Value Add (GVA), important though these are. The underlying technologies in our portfolio have the potential to transform lives through improved health, a cleaner environment and a more secure society in future generations. For example:
Nemesis Bioscience today announced the successful completion of its latest funding round, bringing total...
read moreBritish molecular diagnostics company Cytox plans to make a molecular test for the early-stage...
read more